Effect of Combined Treatment with mTOR Inhibitors (mTORi) and Dopamine Agonists on Cell Proliferation in a Human Typical Lung Carcinoid Cell Line
#919
Introduction: The mTOR pathway and dopamine receptors are potential targets for treatment of neuroendocrine tumors (NET).
Aim(s): To evaluate the in vitro effect of combined treatment with the mTORi rapamycin (RAP) or everolimus (EVE) and the dopamine agonist cabergoline (CAB) on cell proliferation in a typical human lung carcinoid cell line (H727).
Materials and methods: The expression of some components of mTOR pathway and D2 receptor was assessed by RT-qPCR and immunostaining. The effect of mTORi and CAB on cell viability and cell cycle was evaluated by MTT assay and flow-cytometry, respectively.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Sarnataro M
Authors: Sarnataro M, Pivonello C, De Martino M, Sciammarella C, Cuomo G,
To read the full abstract, please log into your ENETS Member account.